Global Human Microbiome Market Insights and Forecast to 2031

Report ID: 1541184 | Published Date: Sep 2024 | No. of Page: 114 | Base Year: 2023 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Human Microbiome Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Gastrointestinal Tract Human Micobiome
        1.2.3 Urogenital Tract Human Micobiome
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Human Microbiome Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Treatment
        1.3.3 Diagnosis
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Human Microbiome Market Perspective (2017-2028)
    2.2 Human Microbiome Growth Trends by Region
        2.2.1 Human Microbiome Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Human Microbiome Historic Market Size by Region (2017-2022)
        2.2.3 Human Microbiome Forecasted Market Size by Region (2023-2028)
    2.3 Human Microbiome Market Dynamics
        2.3.1 Human Microbiome Industry Trends
        2.3.2 Human Microbiome Market Drivers
        2.3.3 Human Microbiome Market Challenges
        2.3.4 Human Microbiome Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Human Microbiome Players by Revenue
        3.1.1 Global Top Human Microbiome Players by Revenue (2017-2022)
        3.1.2 Global Human Microbiome Revenue Market Share by Players (2017-2022)
    3.2 Global Human Microbiome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Human Microbiome Revenue
    3.4 Global Human Microbiome Market Concentration Ratio
        3.4.1 Global Human Microbiome Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Human Microbiome Revenue in 2021
    3.5 Human Microbiome Key Players Head office and Area Served
    3.6 Key Players Human Microbiome Product Solution and Service
    3.7 Date of Enter into Human Microbiome Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Human Microbiome Breakdown Data by Type
    4.1 Global Human Microbiome Historic Market Size by Type (2017-2022)
    4.2 Global Human Microbiome Forecasted Market Size by Type (2023-2028)
5 Human Microbiome Breakdown Data by Application
    5.1 Global Human Microbiome Historic Market Size by Application (2017-2022)
    5.2 Global Human Microbiome Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Human Microbiome Market Size (2017-2028)
    6.2 North America Human Microbiome Market Size by Type
        6.2.1 North America Human Microbiome Market Size by Type (2017-2022)
        6.2.2 North America Human Microbiome Market Size by Type (2023-2028)
        6.2.3 North America Human Microbiome Market Share by Type (2017-2028)
    6.3 North America Human Microbiome Market Size by Application
        6.3.1 North America Human Microbiome Market Size by Application (2017-2022)
        6.3.2 North America Human Microbiome Market Size by Application (2023-2028)
        6.3.3 North America Human Microbiome Market Share by Application (2017-2028)
    6.4 North America Human Microbiome Market Size by Country
        6.4.1 North America Human Microbiome Market Size by Country (2017-2022)
        6.4.2 North America Human Microbiome Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Human Microbiome Market Size (2017-2028)
    7.2 Europe Human Microbiome Market Size by Type
        7.2.1 Europe Human Microbiome Market Size by Type (2017-2022)
        7.2.2 Europe Human Microbiome Market Size by Type (2023-2028)
        7.2.3 Europe Human Microbiome Market Share by Type (2017-2028)
    7.3 Europe Human Microbiome Market Size by Application
        7.3.1 Europe Human Microbiome Market Size by Application (2017-2022)
        7.3.2 Europe Human Microbiome Market Size by Application (2023-2028)
        7.3.3 Europe Human Microbiome Market Share by Application (2017-2028)
    7.4 Europe Human Microbiome Market Size by Country
        7.4.1 Europe Human Microbiome Market Size by Country (2017-2022)
        7.4.2 Europe Human Microbiome Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Human Microbiome Market Size (2017-2028)
    8.2 Asia-Pacific Human Microbiome Market Size by Type
        8.2.1 Asia-Pacific Human Microbiome Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Human Microbiome Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Human Microbiome Market Share by Type (2017-2028)
    8.3 Asia-Pacific Human Microbiome Market Size by Application
        8.3.1 Asia-Pacific Human Microbiome Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Human Microbiome Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Human Microbiome Market Share by Application (2017-2028)
    8.4 Asia-Pacific Human Microbiome Market Size by Region
        8.4.1 Asia-Pacific Human Microbiome Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Human Microbiome Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Human Microbiome Market Size (2017-2028)
    9.2 Latin America Human Microbiome Market Size by Type
        9.2.1 Latin America Human Microbiome Market Size by Type (2017-2022)
        9.2.2 Latin America Human Microbiome Market Size by Type (2023-2028)
        9.2.3 Latin America Human Microbiome Market Share by Type (2017-2028)
    9.3 Latin America Human Microbiome Market Size by Application
        9.3.1 Latin America Human Microbiome Market Size by Application (2017-2022)
        9.3.2 Latin America Human Microbiome Market Size by Application (2023-2028)
        9.3.3 Latin America Human Microbiome Market Share by Application (2017-2028)
    9.4 Latin America Human Microbiome Market Size by Country
        9.4.1 Latin America Human Microbiome Market Size by Country (2017-2022)
        9.4.2 Latin America Human Microbiome Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Human Microbiome Market Size (2017-2028)
    10.2 Middle East & Africa Human Microbiome Market Size by Type
        10.2.1 Middle East & Africa Human Microbiome Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Human Microbiome Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Human Microbiome Market Share by Type (2017-2028)
    10.3 Middle East & Africa Human Microbiome Market Size by Application
        10.3.1 Middle East & Africa Human Microbiome Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Human Microbiome Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Human Microbiome Market Share by Application (2017-2028)
    10.4 Middle East & Africa Human Microbiome Market Size by Country
        10.4.1 Middle East & Africa Human Microbiome Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Human Microbiome Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Vedanta
        11.1.1 Vedanta Company Details
        11.1.2 Vedanta Business Overview
        11.1.3 Vedanta Human Microbiome Introduction
        11.1.4 Vedanta Revenue in Human Microbiome Business (2017-2022)
        11.1.5 Vedanta Recent Developments
    11.2 Seres Therapeutics
        11.2.1 Seres Therapeutics Company Details
        11.2.2 Seres Therapeutics Business Overview
        11.2.3 Seres Therapeutics Human Microbiome Introduction
        11.2.4 Seres Therapeutics Revenue in Human Microbiome Business (2017-2022)
        11.2.5 Seres Therapeutics Recent Developments
    11.3 Second Genome
        11.3.1 Second Genome Company Details
        11.3.2 Second Genome Business Overview
        11.3.3 Second Genome Human Microbiome Introduction
        11.3.4 Second Genome Revenue in Human Microbiome Business (2017-2022)
        11.3.5 Second Genome Recent Developments
    11.4 Rebiotix
        11.4.1 Rebiotix Company Details
        11.4.2 Rebiotix Business Overview
        11.4.3 Rebiotix Human Microbiome Introduction
        11.4.4 Rebiotix Revenue in Human Microbiome Business (2017-2022)
        11.4.5 Rebiotix Recent Developments
    11.5 ActoGeniX
        11.5.1 ActoGeniX Company Details
        11.5.2 ActoGeniX Business Overview
        11.5.3 ActoGeniX Human Microbiome Introduction
        11.5.4 ActoGeniX Revenue in Human Microbiome Business (2017-2022)
        11.5.5 ActoGeniX Recent Developments
    11.6 Enterome BioScience
        11.6.1 Enterome BioScience Company Details
        11.6.2 Enterome BioScience Business Overview
        11.6.3 Enterome BioScience Human Microbiome Introduction
        11.6.4 Enterome BioScience Revenue in Human Microbiome Business (2017-2022)
        11.6.5 Enterome BioScience Recent Developments
    11.7 AvidBiotics
        11.7.1 AvidBiotics Company Details
        11.7.2 AvidBiotics Business Overview
        11.7.3 AvidBiotics Human Microbiome Introduction
        11.7.4 AvidBiotics Revenue in Human Microbiome Business (2017-2022)
        11.7.5 AvidBiotics Recent Developments
    11.8 4D Pharma Research Ltd
        11.8.1 4D Pharma Research Ltd Company Details
        11.8.2 4D Pharma Research Ltd Business Overview
        11.8.3 4D Pharma Research Ltd Human Microbiome Introduction
        11.8.4 4D Pharma Research Ltd Revenue in Human Microbiome Business (2017-2022)
        11.8.5 4D Pharma Research Ltd Recent Developments
    11.9 Enterologics
        11.9.1 Enterologics Company Details
        11.9.2 Enterologics Business Overview
        11.9.3 Enterologics Human Microbiome Introduction
        11.9.4 Enterologics Revenue in Human Microbiome Business (2017-2022)
        11.9.5 Enterologics Recent Developments
    11.10 Metabogen
        11.10.1 Metabogen Company Details
        11.10.2 Metabogen Business Overview
        11.10.3 Metabogen Human Microbiome Introduction
        11.10.4 Metabogen Revenue in Human Microbiome Business (2017-2022)
        11.10.5 Metabogen Recent Developments
    11.11 Metabiomics
        11.11.1 Metabiomics Company Details
        11.11.2 Metabiomics Business Overview
        11.11.3 Metabiomics Human Microbiome Introduction
        11.11.4 Metabiomics Revenue in Human Microbiome Business (2017-2022)
        11.11.5 Metabiomics Recent Developments
    11.12 Ritter Pharmaceuticals
        11.12.1 Ritter Pharmaceuticals Company Details
        11.12.2 Ritter Pharmaceuticals Business Overview
        11.12.3 Ritter Pharmaceuticals Human Microbiome Introduction
        11.12.4 Ritter Pharmaceuticals Revenue in Human Microbiome Business (2017-2022)
        11.12.5 Ritter Pharmaceuticals Recent Developments
    11.13 Osel
        11.13.1 Osel Company Details
        11.13.2 Osel Business Overview
        11.13.3 Osel Human Microbiome Introduction
        11.13.4 Osel Revenue in Human Microbiome Business (2017-2022)
        11.13.5 Osel Recent Developments
    11.14 Symberix
        11.14.1 Symberix Company Details
        11.14.2 Symberix Business Overview
        11.14.3 Symberix Human Microbiome Introduction
        11.14.4 Symberix Revenue in Human Microbiome Business (2017-2022)
        11.14.5 Symberix Recent Developments
    11.15 Miomics
        11.15.1 Miomics Company Details
        11.15.2 Miomics Business Overview
        11.15.3 Miomics Human Microbiome Introduction
        11.15.4 Miomics Revenue in Human Microbiome Business (2017-2022)
        11.15.5 Miomics Recent Developments
    11.16 Symbiotix Biotherapies
        11.16.1 Symbiotix Biotherapies Company Details
        11.16.2 Symbiotix Biotherapies Business Overview
        11.16.3 Symbiotix Biotherapies Human Microbiome Introduction
        11.16.4 Symbiotix Biotherapies Revenue in Human Microbiome Business (2017-2022)
        11.16.5 Symbiotix Biotherapies Recent Developments
    11.17 MicroBiome Therapeutics LLC
        11.17.1 MicroBiome Therapeutics LLC Company Details
        11.17.2 MicroBiome Therapeutics LLC Business Overview
        11.17.3 MicroBiome Therapeutics LLC Human Microbiome Introduction
        11.17.4 MicroBiome Therapeutics LLC Revenue in Human Microbiome Business (2017-2022)
        11.17.5 MicroBiome Therapeutics LLC Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Human Microbiome Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Gastrointestinal Tract Human Micobiome
    Table 3. Key Players of Urogenital Tract Human Micobiome
    Table 4. Key Players of Others
    Table 5. Global Human Microbiome Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Human Microbiome Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Human Microbiome Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Human Microbiome Market Share by Region (2017-2022)
    Table 9. Global Human Microbiome Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Human Microbiome Market Share by Region (2023-2028)
    Table 11. Human Microbiome Market Trends
    Table 12. Human Microbiome Market Drivers
    Table 13. Human Microbiome Market Challenges
    Table 14. Human Microbiome Market Restraints
    Table 15. Global Human Microbiome Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Human Microbiome Revenue Share by Players (2017-2022)
    Table 17. Global Top Human Microbiome by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome as of 2021)
    Table 18. Ranking of Global Top Human Microbiome Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Human Microbiome Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Human Microbiome Product Solution and Service
    Table 22. Date of Enter into Human Microbiome Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Human Microbiome Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Human Microbiome Revenue Market Share by Type (2017-2022)
    Table 26. Global Human Microbiome Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Human Microbiome Revenue Market Share by Type (2023-2028)
    Table 28. Global Human Microbiome Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Human Microbiome Revenue Share by Application (2017-2022)
    Table 30. Global Human Microbiome Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Human Microbiome Revenue Share by Application (2023-2028)
    Table 32. North America Human Microbiome Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Human Microbiome Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Human Microbiome Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Human Microbiome Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Human Microbiome Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Human Microbiome Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Human Microbiome Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Human Microbiome Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Human Microbiome Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Human Microbiome Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Human Microbiome Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Human Microbiome Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Human Microbiome Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Human Microbiome Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Human Microbiome Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Human Microbiome Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Human Microbiome Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Human Microbiome Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Human Microbiome Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Human Microbiome Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Human Microbiome Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Human Microbiome Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Human Microbiome Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Human Microbiome Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Human Microbiome Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Human Microbiome Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Human Microbiome Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Human Microbiome Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Human Microbiome Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Human Microbiome Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Vedanta Company Details
    Table 63. Vedanta Business Overview
    Table 64. Vedanta Human Microbiome Product
    Table 65. Vedanta Revenue in Human Microbiome Business (2017-2022) & (US$ Million)
    Table 66. Vedanta Recent Developments
    Table 67. Seres Therapeutics Company Details
    Table 68. Seres Therapeutics Business Overview
    Table 69. Seres Therapeutics Human Microbiome Product
    Table 70. Seres Therapeutics Revenue in Human Microbiome Business (2017-2022) & (US$ Million)
    Table 71. Seres Therapeutics Recent Developments
    Table 72. Second Genome Company Details
    Table 73. Second Genome Business Overview
    Table 74. Second Genome Human Microbiome Product
    Table 75. Second Genome Revenue in Human Microbiome Business (2017-2022) & (US$ Million)
    Table 76. Second Genome Recent Developments
    Table 77. Rebiotix Company Details
    Table 78. Rebiotix Business Overview
    Table 79. Rebiotix Human Microbiome Product
    Table 80. Rebiotix Revenue in Human Microbiome Business (2017-2022) & (US$ Million)
    Table 81. Rebiotix Recent Developments
    Table 82. ActoGeniX Company Details
    Table 83. ActoGeniX Business Overview
    Table 84. ActoGeniX Human Microbiome Product
    Table 85. ActoGeniX Revenue in Human Microbiome Business (2017-2022) & (US$ Million)
    Table 86. ActoGeniX Recent Developments
    Table 87. Enterome BioScience Company Details
    Table 88. Enterome BioScience Business Overview
    Table 89. Enterome BioScience Human Microbiome Product
    Table 90. Enterome BioScience Revenue in Human Microbiome Business (2017-2022) & (US$ Million)
    Table 91. Enterome BioScience Recent Developments
    Table 92. AvidBiotics Company Details
    Table 93. AvidBiotics Business Overview
    Table 94. AvidBiotics Human Microbiome Product
    Table 95. AvidBiotics Revenue in Human Microbiome Business (2017-2022) & (US$ Million)
    Table 96. AvidBiotics Recent Developments
    Table 97. 4D Pharma Research Ltd Company Details
    Table 98. 4D Pharma Research Ltd Business Overview
    Table 99. 4D Pharma Research Ltd Human Microbiome Product
    Table 100. 4D Pharma Research Ltd Revenue in Human Microbiome Business (2017-2022) & (US$ Million)
    Table 101. 4D Pharma Research Ltd Recent Developments
    Table 102. Enterologics Company Details
    Table 103. Enterologics Business Overview
    Table 104. Enterologics Human Microbiome Product
    Table 105. Enterologics Revenue in Human Microbiome Business (2017-2022) & (US$ Million)
    Table 106. Enterologics Recent Developments
    Table 107. Metabogen Company Details
    Table 108. Metabogen Business Overview
    Table 109. Metabogen Human Microbiome Product
    Table 110. Metabogen Revenue in Human Microbiome Business (2017-2022) & (US$ Million)
    Table 111. Metabogen Recent Developments
    Table 112. Metabiomics Company Details
    Table 113. Metabiomics Business Overview
    Table 114. Metabiomics Human Microbiome Product
    Table 115. Metabiomics Revenue in Human Microbiome Business (2017-2022) & (US$ Million)
    Table 116. Metabiomics Recent Developments
    Table 117. Ritter Pharmaceuticals Company Details
    Table 118. Ritter Pharmaceuticals Business Overview
    Table 119. Ritter Pharmaceuticals Human Microbiome Product
    Table 120. Ritter Pharmaceuticals Revenue in Human Microbiome Business (2017-2022) & (US$ Million)
    Table 121. Ritter Pharmaceuticals Recent Developments
    Table 122. Osel Company Details
    Table 123. Osel Business Overview
    Table 124. Osel Human Microbiome Product
    Table 125. Osel Revenue in Human Microbiome Business (2017-2022) & (US$ Million)
    Table 126. Osel Recent Developments
    Table 127. Symberix Company Details
    Table 128. Symberix Business Overview
    Table 129. Symberix Human Microbiome Product
    Table 130. Symberix Revenue in Human Microbiome Business (2017-2022) & (US$ Million)
    Table 131. Symberix Recent Developments
    Table 132. Miomics Company Details
    Table 133. Miomics Business Overview
    Table 134. Miomics Human Microbiome Product
    Table 135. Miomics Revenue in Human Microbiome Business (2017-2022) & (US$ Million)
    Table 136. Miomics Recent Developments
    Table 137. Symbiotix Biotherapies Company Details
    Table 138. Symbiotix Biotherapies Business Overview
    Table 139. Symbiotix Biotherapies Human Microbiome Product
    Table 140. Symbiotix Biotherapies Revenue in Human Microbiome Business (2017-2022) & (US$ Million)
    Table 141. Symbiotix Biotherapies Recent Developments
    Table 142. MicroBiome Therapeutics LLC Company Details
    Table 143. MicroBiome Therapeutics LLC Business Overview
    Table 144. MicroBiome Therapeutics LLC Human Microbiome Product
    Table 145. MicroBiome Therapeutics LLC Revenue in Human Microbiome Business (2017-2022) & (US$ Million)
    Table 146. MicroBiome Therapeutics LLC Recent Developments
    Table 147. Research Programs/Design for This Report
    Table 148. Key Data Information from Secondary Sources
    Table 149. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Human Microbiome Market Share by Type: 2021 VS 2028
    Figure 2. Gastrointestinal Tract Human Micobiome Features
    Figure 3. Urogenital Tract Human Micobiome Features
    Figure 4. Others Features
    Figure 5. Global Human Microbiome Market Share by Application: 2021 VS 2028
    Figure 6. Treatment Case Studies
    Figure 7. Diagnosis Case Studies
    Figure 8. Human Microbiome Report Years Considered
    Figure 9. Global Human Microbiome Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Human Microbiome Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Human Microbiome Market Share by Region: 2021 VS 2028
    Figure 12. Global Human Microbiome Market Share by Players in 2021
    Figure 13. Global Top Human Microbiome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Human Microbiome Revenue in 2021
    Figure 15. North America Human Microbiome Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Human Microbiome Market Size Market Share by Type (2017-2028)
    Figure 17. North America Human Microbiome Market Size Market Share by Application (2017-2028)
    Figure 18. North America Human Microbiome Market Size Share by Country (2017-2028)
    Figure 19. United States Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Human Microbiome Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Human Microbiome Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Human Microbiome Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Human Microbiome Market Size Share by Country (2017-2028)
    Figure 25. Germany Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Human Microbiome Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Human Microbiome Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Human Microbiome Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Human Microbiome Market Size Share by Region (2017-2028)
    Figure 35. China Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America Human Microbiome Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Human Microbiome Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Human Microbiome Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Human Microbiome Market Size Share by Country (2017-2028)
    Figure 45. Mexico Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Human Microbiome Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Human Microbiome Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Human Microbiome Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Human Microbiome Market Size Share by Country (2017-2028)
    Figure 51. Turkey Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Vedanta Revenue Growth Rate in Human Microbiome Business (2017-2022)
    Figure 55. Seres Therapeutics Revenue Growth Rate in Human Microbiome Business (2017-2022)
    Figure 56. Second Genome Revenue Growth Rate in Human Microbiome Business (2017-2022)
    Figure 57. Rebiotix Revenue Growth Rate in Human Microbiome Business (2017-2022)
    Figure 58. ActoGeniX Revenue Growth Rate in Human Microbiome Business (2017-2022)
    Figure 59. Enterome BioScience Revenue Growth Rate in Human Microbiome Business (2017-2022)
    Figure 60. AvidBiotics Revenue Growth Rate in Human Microbiome Business (2017-2022)
    Figure 61. 4D Pharma Research Ltd Revenue Growth Rate in Human Microbiome Business (2017-2022)
    Figure 62. Enterologics Revenue Growth Rate in Human Microbiome Business (2017-2022)
    Figure 63. Metabogen Revenue Growth Rate in Human Microbiome Business (2017-2022)
    Figure 64. Metabiomics Revenue Growth Rate in Human Microbiome Business (2017-2022)
    Figure 65. Ritter Pharmaceuticals Revenue Growth Rate in Human Microbiome Business (2017-2022)
    Figure 66. Osel Revenue Growth Rate in Human Microbiome Business (2017-2022)
    Figure 67. Symberix Revenue Growth Rate in Human Microbiome Business (2017-2022)
    Figure 68. Miomics Revenue Growth Rate in Human Microbiome Business (2017-2022)
    Figure 69. Symbiotix Biotherapies Revenue Growth Rate in Human Microbiome Business (2017-2022)
    Figure 70. MicroBiome Therapeutics LLC Revenue Growth Rate in Human Microbiome Business (2017-2022)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Vedanta
Seres Therapeutics
Second Genome
Rebiotix
ActoGeniX
Enterome BioScience
AvidBiotics
4D Pharma Research Ltd
Enterologics
Metabogen
Metabiomics
Ritter Pharmaceuticals
Osel
Symberix
Miomics
Symbiotix Biotherapies
MicroBiome Therapeutics LLC
Frequently Asked Questions
Human Microbiome report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Human Microbiome report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Human Microbiome report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Air Seeder

Air Seeder market is segmented by Type and by Application. Players, stakeholders, and other parti ... Read More